The newly identified LNC000093 served as a competitive endogenous RNA for miR-675-5p and reversed the imatinib resistance in CML cells through regulating RUNX1 expression. The gene discussed is RUNX1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.